Industry
Thought leaders sharing decades of industry experience through publications and research
Press Releases
The Society for Clinical Research Sites (SCRS) First in Kind Diversity Site Solutions Summit
April 13, 2022 The Society of Clinical Research Sites (SCRS) will be hosting its inaugural Diversity Site Solutions Summit on 20 May 2022 in Austin, Texas. This …
Total Diversity Clinical Trial Management Provides Signature Voice Sponsorship for First Site-Focused Diversity Conference in the Clinical Trials Industry
Amanda Rangel Dallas, Texas, April 12, 2022 – Total Diversity Clinical Trial Management, a global Contract Research Organization and full-service Diversity Organization, is supporting the Society …
Total Diversity Clinical Trial Management Sponsors First Site-Focused Diversity Conference in the Clinical Trials Industry
Amanda Rangel Dallas, Texas, April 28, 2022 – Total Diversity Clinical Trial Management, a global Contract Research Organization and full-service Diversity Organization, has announced Mark Hanley …
Conferences
Research Articles
Diversity and Inclusion in Clinical Trials
Diana Foster, Ph.D.CEO, Total Diversity Clinical Trials Management One of the most important new areas of emphasis in the clinical trials industry today is the …
Identify Opportunities to Improve Diversity Recruitment
Diana Foster, PhD. || While it’s important to note that there are areas where the industry can improve, there are unique opportunities of improvement for …
The Diversity Site Assessment Tool (DSAT), Reliability and Validity of the Industry Gold Standard for Establishing Investigator Site Ranking
Diana Foster, Ph.D. Vice President, Strategy and Special Projects, Society of Clinical Research Site ABSTRACT Background: The purpose of this study was to evaluate the reliability …
Consultative Opportunities
Dr. Diana Foster, Ph.D
An innovative leader
Diana Foster is a recognized expert in the intricacies of site management and an innovator in the use of strategic marketing and positioning tactics, her focus and strategic guidance in the area of diversity among clinical trials positions Diana as a continued thought leader related to this critical movement in the clinical trial industry.